Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.

Violatto MB, Casarin E, Talamini L, Russo L, Baldan S, Tondello C, Messmer M, Hintermann E, Rossi A, Passoni A, Bagnati R, Biffi S, Toffanin C, Gimondi S, Fumagalli S, De Simoni MG, Barisani D, Salmona M, Christen U, Invernizzi P, Bigini P, Morpurgo M.

ACS Nano. 2019 Mar 18. doi: 10.1021/acsnano.8b09655. [Epub ahead of print]

PMID:
30883091
2.

Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.

Toffanin C, Visentin R, Messori M, Palma FD, Magni L, Cobelli C.

IEEE Trans Biomed Eng. 2018 Mar;65(3):479-488. doi: 10.1109/TBME.2017.2652062. Epub 2017 Jan 11.

PMID:
28092515
3.

Model individualization for artificial pancreas.

Messori M, Toffanin C, Del Favero S, De Nicolao G, Cobelli C, Magni L.

Comput Methods Programs Biomed. 2019 Apr;171:133-140. doi: 10.1016/j.cmpb.2016.06.006. Epub 2016 Jul 5.

PMID:
27424482
4.

Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.

Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, Visentin R, Calore R, Toffanin C, Di Palma F, Lanzola G, Magni P, Boscari F, Galasso S, Avogaro A, Keith-Hynes P, Kovatchev B, Del Favero S, Cobelli C, Magni L, DeVries JH; AP@home Consortium.

Diabetes Care. 2016 Jul;39(7):1151-60. doi: 10.2337/dc16-0008. Epub 2016 May 5.

PMID:
27208331
5.

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.

Kropff J, Del Favero S, Place J, Toffanin C, Visentin R, Monaro M, Messori M, Di Palma F, Lanzola G, Farret A, Boscari F, Galasso S, Magni P, Avogaro A, Keith-Hynes P, Kovatchev BP, Bruttomesso D, Cobelli C, DeVries JH, Renard E, Magni L; AP@home consortium.

Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47. doi: 10.1016/S2213-8587(15)00335-6. Epub 2015 Sep 30.

PMID:
26432775
6.

Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.

Del Favero S, Place J, Kropff J, Messori M, Keith-Hynes P, Visentin R, Monaro M, Galasso S, Boscari F, Toffanin C, Di Palma F, Lanzola G, Scarpellini S, Farret A, Kovatchev B, Avogaro A, Bruttomesso D, Magni L, DeVries JH, Cobelli C, Renard E; AP@home Consortium.

Diabetes Obes Metab. 2015 May;17(5):468-76. doi: 10.1111/dom.12440. Epub 2015 Feb 16.

PMID:
25600304
7.

Designing an artificial pancreas architecture: the AP@home experience.

Lanzola G, Toffanin C, Di Palma F, Del Favero S, Magni L, Bellazzi R.

Med Biol Eng Comput. 2015 Dec;53(12):1271-83. doi: 10.1007/s11517-014-1231-1. Epub 2014 Nov 28.

PMID:
25430423
8.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Zisser H, Renard E, Kovatchev B, Cobelli C, Avogaro A, Nimri R, Magni L, Buckingham BA, Chase HP, Doyle FJ 3rd, Lum J, Calhoun P, Kollman C, Dassau E, Farret A, Place J, Breton M, Anderson SM, Dalla Man C, Del Favero S, Bruttomesso D, Filippi A, Scotton R, Phillip M, Atlas E, Muller I, Miller S, Toffanin C, Raimondo DM, De Nicolao G, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):613-22. doi: 10.1089/dia.2014.0066. Epub 2014 Jul 8. Erratum in: Diabetes Technol Ther. 2015 Jan;17(1):68. Vistenin, Roberto [corrected to Visentin, Roberto].

9.

Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassau E, Doyle FJ 3rd.

Diabetes Care. 2014 Jul;37(7):1789-96. doi: 10.2337/dc13-2076. Epub 2014 Jun 14.

10.

Monitoring Artificial Pancreas Trials Through Agent-based Technologies: A Case Report.

Lanzola G, Scarpellini S, Di Palma F, Toffanin C, Del Favero S, Magni L, Bellazzi R; on behalf of the AP@home consortium.

J Diabetes Sci Technol. 2014 Mar;8(2):216-224. Epub 2014 Mar 2.

11.

First use of model predictive control in outpatient wearable artificial pancreas.

Del Favero S, Bruttomesso D, Di Palma F, Lanzola G, Visentin R, Filippi A, Scotton R, Toffanin C, Messori M, Scarpellini S, Keith-Hynes P, Kovatchev BP, Devries JH, Renard E, Magni L, Avogaro A, Cobelli C; AP@home Consortium.

Diabetes Care. 2014;37(5):1212-5. doi: 10.2337/dc13-1631.

PMID:
24757228
12.

Artificial pancreas: model predictive control design from clinical experience.

Toffanin C, Messori M, Di Palma F, De Nicolao G, Cobelli C, Magni L.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1470-83.

13.

Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.

Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L; AP@home Consortium.

Diabetes Care. 2013 Dec;36(12):3882-7. doi: 10.2337/dc12-1956. Epub 2013 Oct 29.

14.

Dynamic insulin on board: incorporation of circadian insulin sensitivity variation.

Toffanin C, Zisser H, Doyle FJ 3rd, Dassau E.

J Diabetes Sci Technol. 2013 Jul 1;7(4):928-40.

15.

Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.

Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group.

Diabetes. 2012 Sep;61(9):2230-7. Epub 2012 Jun 11.

16.

Modular closed-loop control of diabetes.

Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ 3rd, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group.

IEEE Trans Biomed Eng. 2012 Nov;59(11):2986-99. doi: 10.1109/TBME.2012.2192930. Epub 2012 Apr 3.

17.

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Magni L, Forgione M, Toffanin C, Dalla Man C, Kovatchev B, De Nicolao G, Cobelli C.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1091-8.

Supplemental Content

Loading ...
Support Center